Turn on gene to treat disease by RNAa

FOLLOW OUR PROGRESS

CB Insights lists Ractigen as one of the Top RNA biotech companies in China

Tuesday, May 19, 2020

CB Insights lists Ractigen as one of the Top RNA biotech companies in China

[May 19th, 2020] Today, CB Insights China published, for the first time, a top list of RNA biotech companies in China and Ractigen Therapeutics, as the only company developing RNAa therapeutics, is listed as top 3.

CB Insights is a world-renowned venture capital analysis institution which publishes investment analysis reports in various industries and fields which are adopted by many VCs in their database and think tanks for decision-making.

“RNAa technology will open up a brand new field in pharmaceutical industry with a bright market prospect, if Ractigen’s programs advance smoothly.” said CB Insights.